Product Information
FENOFIBRATE 134 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1141 per EA under NDC 68462058101. Its NADAC has been published 477 times since May 10, 2017.
Strength
134 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462058101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205566On Market Since
4/7/2017
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 134 MG CAPSULE has been published 477 times since May 10, 2017, and over the history we have for it it has declined 89.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1141 per EA |
|---|---|
| All-time high | $1.0448 (May 10, 2017) |
| All-time low | $0.1020 (Nov 20, 2024) |
| 52-week high | $0.1391 |
| 52-week low | $0.1101 |
| Median price | $0.1815 |
| Average price | $0.2968 |
| Largest weekly change | +38.9% (Sep 23, 2020) |
| Weeks tracked | 477 |
| Tracking since | May 10, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 134 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 134 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1141 per EA (NDC 68462058101), effective Jun 24, 2026.
How has the price of FENOFIBRATE 134 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 134 MG CAPSULE has declined 89.1%. It has been tracked across 477 weekly CMS publications since May 10, 2017.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 134 MG CAPSULE?
Since May 10, 2017, the NADAC for FENOFIBRATE 134 MG CAPSULE has ranged from a low of $0.1020 (Nov 20, 2024) to a high of $1.0448 (May 10, 2017), with a median of $0.1815 per EA.
Are there cheaper alternatives to FENOFIBRATE 134 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, FENOFIBRATE 134 MG CAPSULE, is $0.1089 per EA — about 5% below FENOFIBRATE 134 MG CAPSULE.
Who manufactures FENOFIBRATE 134 MG CAPSULE?
FENOFIBRATE 134 MG CAPSULE (NDC 68462058101) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification